Is Low FODMAP Good for Crohn's? The Evidence

A low FODMAP diet is good for one job in Crohn's disease, and it is not the job most people hope for. It can reduce bloating, wind, cramping and urgency when your Crohn's is already under control but your gut has not got the memo. It does not reduce inflammation, it does not keep you in remission, and it will not replace anything your IBD team has you on.

That sounds like a let-down until you notice how often it is exactly the problem people have. You get the biologic working, the scope comes back clean, the calprotectin is fine, and you still cannot eat a bowl of pasta without spending the evening doubled over. This article is about whether a low FODMAP diet is the right tool for that, what the trials in Crohn's specifically found, and the Crohn's-only complications that most low FODMAP articles never mention.

The short answer: good for symptoms, not for the disease

Split "is low FODMAP good for Crohn's" into two questions and both become answerable. Does it help gut symptoms? Usually, if the symptoms are the functional kind. Does it do anything to Crohn's itself? No, and the most recent evidence review says so plainly.

A 2025 systematic review and meta-analysis pooled five randomised controlled trials of a low FODMAP diet in IBD covering 224 people. Compared with control diets, there was no effect on disease activity in Crohn's disease (standardised mean difference -0.33, confidence interval -0.77 to 0.11), none in ulcerative colitis, and none on faecal calprotectin (-0.20, -0.49 to 0.09). Global IBS symptom severity was lower (-0.56, -0.90 to -0.23) and quality of life higher (0.43, 0.05 to 0.81). The authors concluded that the diet should be considered for improving functional gastrointestinal symptoms but is not an IBD treatment (Ville 2025).

Guidelines have landed in the same place, and the wording is unusually clear for a diet question. The 2025 European Crohn's and Colitis Organisation consensus recommends a low FODMAP diet in adults with quiescent IBD and IBS-like symptoms to treat persistent gastrointestinal symptoms, and separately states that a low FODMAP diet is not recommended for maintenance of remission in Crohn's disease (Svolos 2025).

This is not a technicality. Those two statements are doing different work, and most of the confusion in Crohn's communities comes from collapsing them into one. In a widely read r/CrohnsDisease thread asking whether anyone's doctor had mentioned FODMAPs, the highest-voted replies said versions of the same thing: the diet was built for IBS, it can help some IBD symptoms, and it will not treat inflammation (r/CrohnsDisease thread). That community read of the evidence is, as it happens, exactly right.

So somewhere between a quarter and a third of people with Crohn's in remission are living with gut symptoms that their anti-inflammatory treatment was never going to touch. That is the population the low FODMAP evidence actually applies to.

What the trials in Crohn's found, and what they missed

The honest summary is that the evidence is positive for symptoms, thinner than the headlines suggest, and mostly conducted in mixed groups of Crohn's and ulcerative colitis rather than Crohn's alone.

The main randomised trial. Fifty-two people with quiescent Crohn's or ulcerative colitis and persistent gut symptoms were randomised to four weeks of a low FODMAP diet or a control diet at two UK clinics. More people on the low FODMAP diet reported adequate relief of gut symptoms (14 of 27, 52%) than on the control diet (4 of 25, 16%, P=.007), and health-related quality of life was higher. Markers of inflammation did not differ between groups (Cox 2020).

It is worth being precise about that trial, because it gets quoted as a slam dunk. The reduction in IBS severity scores, an important continuous outcome, was larger on the low FODMAP diet but did not reach statistical significance (mean reduction 67 versus 34, P=.075). The authors' own conclusion states that they found no significant difference in change in IBS severity scores, alongside the significant improvements in specific symptoms and in the number reporting adequate relief. It is a positive trial on the outcome that arguably matters most to patients, and a miss on the severity score.

The meta-analyses agree on the shape and differ on the strength. A 2022 meta-analysis of nine studies including 446 participants found the diet alleviated overall functional gastrointestinal symptoms (relative risk 0.47), improved IBD quality of life scores, and lowered the Harvey-Bradshaw index in Crohn's by about one point. There was no significant difference in stool consistency, Bristol scores or faecal calprotectin (Peng 2022). A one-point drop in Harvey-Bradshaw is worth noting carefully: that index is built largely from symptoms such as wellbeing, pain and stool frequency, so an improvement there is not evidence that inflammation moved.

A stricter 2020 systematic review that looked only at randomised trials was noticeably more cautious. It found four eligible trials, three with risk-of-bias concerns, too much heterogeneity to pool, inconsistent findings on stool frequency and short-chain fatty acids, and no differences in calprotectin, CRP or T-cell phenotype. Its conclusion was that the available data were not sufficient to justify the claim that the diet relieves functional symptoms, and that it might in part reflect a placebo response (Grammatikopoulou 2020). That reading has been overtaken by the larger 2025 pooling, but it is a reasonable caution to keep in your head: diet trials cannot be blinded the way drug trials can.

The most convincing mechanism evidence is a rechallenge trial. Twenty-nine people with quiescent IBD whose symptoms had responded to a low FODMAP diet (12 with Crohn's, 17 with ulcerative colitis) were given blinded three-day challenges of fructan, galacto-oligosaccharides, sorbitol or glucose placebo in random order. Only fructan produced a significant effect: fewer people reported adequate relief on the final day (62.1% versus 89.7%) and pain, bloating, flatulence and faecal urgency were all worse than on glucose (Cox 2017). GOS and sorbitol did not. This is the single strongest piece of evidence that something specific is going on rather than expectation alone, and it points at one FODMAP group rather than all of them.

The real-world and observational data are more flattering, as usual. In routine dietetic practice with 88 people with IBD, satisfactory symptom relief rose from 16% at baseline to 78% after low FODMAP education (Prince 2016). An open-label randomised trial of 89 people with IBD found 81% responders on the diet versus 46% on a normal diet (Pedersen 2017). A Crohn's-only study in Egypt followed 100 people in remission with functional symptoms and reported a mean symptom improvement score of 38% at three months, with 67% sticking to the diet (Elhusseiny 2018). None of these were blinded, and open-label diet studies reliably produce larger effects than blinded ones.

Low FODMAP is not a low fibre diet, and in Crohn's that matters

This is the single most common mix-up in Crohn's discussions of diet, and unlike most terminology arguments it has consequences. A low fibre or low residue diet reduces bulk and texture. A low FODMAP diet reduces specific fermentable carbohydrates. They overlap in places and contradict each other in others.

A reduced fibre diet in Crohn's exists to reduce the volume of hard-to-shift material passing through a narrowed section of bowel. It is about physical texture: skins, pips, stalks, raw vegetables, nuts, sweetcorn. The 2025 ECCO consensus is unusually frank that there are no data supporting a modified or low fibre diet for stricturing Crohn's, and that the reasoning is mechanism-based only, at the lowest evidence level (Svolos 2025). The AGA makes a related practical point: people with symptomatic strictures may not tolerate fibrous plant foods because of texture, and careful chewing, cooking and processing to a softer consistency can let them keep more plant foods and fibre in the diet (Hashash 2024).

A low FODMAP diet excludes things for a completely different reason: they are poorly absorbed, osmotically active and rapidly fermented. That is why it restricts wheat, onion, garlic, apples, pears, lactose-containing dairy, legumes and several sweeteners while leaving plenty of bulky and high fibre foods on the list.

The result is that the two diets do not nest inside each other:

• A low FODMAP diet still allows sweetcorn kernels, nuts and seeds, oats, potato skins, raw carrot and green beans. None of those is low residue.
• A low fibre diet still allows white bread, milk, ice cream, honey and fruit juice. None of those is low FODMAP.
• Both allow plain rice, eggs and most meat and fish, which is why "chicken and rice" is what people end up eating on either, and why they get conflated.

The clinical literature actually treats them as separate tools for separate problems. A major review of dietary management in adult IBD sets out a four-step approach where reduced fibre to prevent obstruction in stricturing disease and a low FODMAP diet to manage coexisting functional gut symptoms are listed as two distinct therapeutic uses at the same step (Fitzpatrick 2022).

Reddit shows how tangled this gets in practice. In one r/CrohnsDisease thread, a person newly diagnosed and still on steroids described leaving their dietitian appointment in tears after being told to eat low FODMAP and low fibre and gluten free and dairy free and soy free, all at once, for a month (r/CrohnsDisease thread). Replies were split between "this is standard for healing and it is temporary" and "that is a huge amount to ask". Without seeing the notes, nobody online can say whether that plan was right. What we can say is that it was two different diets stacked on top of each other, aimed at two different problems, at a moment when inflammation was the actual problem. That is worth understanding well enough to ask about.

In the same subreddit, several people said the most useful thing they do is avoid roughage and insoluble fibre, and added in the next breath that "FODMAP is actually for IBS, not IBD" (r/CrohnsDisease thread). Both halves of that sentence are defensible. They are just describing two different diets.

The order of operations: what to settle before you restrict anything

The most useful thing this article can give you is a sequence. In Crohn's, a low FODMAP trial belongs near the end of a list, not at the start, because several things that feel identical to FODMAP sensitivity have specific tests and specific management.

Step 1: confirm the inflammation is actually quiet. Every trial supporting low FODMAP in IBD recruited people in remission. If your Crohn's is active, the diet is not the answer to that, and feeling better on it could disguise a problem that needs treating. Faecal calprotectin is the usual first test. In a meta-analysis of 19 studies and 2,499 people with symptoms of active IBD, faecal calprotectin had a pooled sensitivity of 0.88 and specificity of 0.73 against endoscopy, more sensitive than CRP in both diseases, though somewhat less sensitive in Crohn's than in ulcerative colitis (Mosli 2015). Crohn's can also affect the small bowel where calprotectin performs less well, so your team may want imaging rather than a stool test alone. Our guide on how to tell if you are in a Crohn's flare covers what settles that question and what does not.

Step 2: look for the Crohn's-specific look-alikes. These are covered in the next section, and they are the reason this post exists. Each of them can produce bloating, urgency and loose stools that improve somewhat on a restricted diet while the underlying cause carries on.

Step 3: check the simple mechanical and medication explanations. New symptoms after a change in medication, a course of antibiotics, a recent infection, or regular painkiller use deserve a mention to your team before you rearrange your diet around them.

Step 4: only then consider a structured low FODMAP trial. With a dietitian, with a defined end date, and with reintroduction planned from the start.

Doing these in the wrong order is how people end up eating twelve foods and still feeling awful. The restriction gives partial relief, which feels like confirmation, so the restriction continues, and the actual cause never gets looked at.

Four Crohn's look-alikes a restricted diet will quietly mask

These are more common in Crohn's than in the general population, they all cause fermentation-type symptoms, and none of them is treated with a low FODMAP diet. They are the strongest argument for testing before restricting.

Small intestinal bacterial overgrowth

Bacterial overgrowth produces bloating, wind and loose stools by fermenting carbohydrates in the small bowel. Reducing fermentable carbohydrate will dampen that, which is exactly why it can mask the diagnosis.

A meta-analysis of 11 studies covering 1,175 adults with IBD found SIBO in 22.3%, with an odds ratio of 9.51 compared with non-IBD controls and 10.86 in Crohn's disease specifically. Two things raised the odds sharply within Crohn's: fibrostenosing (stricturing) disease, odds ratio 7.47, and previous bowel surgery, odds ratio 2.38, particularly resection of the ileocaecal valve (Shah 2019). If you have had a resection or have a known narrowing, that is a high enough prior probability to be worth raising.

It may also matter beyond symptoms. In a retrospective cohort of 73 people with quiescent Crohn's who had breath testing, 46.6% were positive for SIBO, and SIBO was independently associated with clinical relapse over 18 months (hazard ratio 2.79) alongside penetrating disease behaviour (Wei 2022). That is one retrospective study at one centre, so treat it as a reason to ask rather than a settled fact.

Bile acid diarrhoea after ileal disease or surgery

The terminal ileum reabsorbs bile acids. If it is inflamed, resected or bypassed, bile acids spill into the colon and cause watery, urgent diarrhoea, often first thing in the morning and often shortly after eating. It looks like a food reaction because it is triggered by eating, but the trigger is the fat-stimulated bile release, not the FODMAP content.

In 91 people with Crohn's who had had a resection and underwent SeHCAT testing, 97% had retention values under 10%, which indicates bile acid malabsorption, and there was a modest correlation between the length of ileum removed and the severity (Skouras 2019). Of those with treatment data, 67% responded to a bile salt binder. That is a specific, testable, treatable cause that no amount of onion avoidance will address.

A thread in r/CrohnsDisease illustrates this well. Someone who had an ileostomy reversal was getting severe bloating and gas after eating, had a clear MRE showing no active Crohn's, and found the low FODMAP diet helped a lot. Commenters raised bacterial overgrowth and bile acid malabsorption, one specifically pointing out that the last part of the small bowel is where bile acids are reabsorbed (r/CrohnsDisease thread). The diet was helping. It was also not the whole story.

Lactose, on its own

Lactose is a FODMAP, so a low FODMAP diet removes it along with everything else. If lactose is your only problem, that is an enormous amount of unnecessary restriction to discover one thing. Small bowel Crohn's can reduce lactase activity, and lactose intolerance is common in plenty of populations regardless of Crohn's. A simple two-week lactose reduction, or a lactose breath test if your team offers one, answers that question far more cheaply.

This is not a theoretical concern. When the main low FODMAP IBS trial was reported, the authors themselves noted it was not clear whether the benefit came from collective FODMAP restriction or from removing a single component such as lactose (Staudacher 2017).

A narrowing that is starting to cause trouble

Obstructive symptoms in Crohn's can be intermittent for a long time before anything dramatic happens: bloating that builds through the day, pain after meals that eases once things move, a rumbling, gurgling abdomen. Eating less, and eating softer, makes all of that better. So does a low FODMAP diet, because you tend to eat less overall on it. Neither addresses a stricture, which is assessed with imaging and managed medically, endoscopically or surgically depending on what it is made of.

The microbiome cost has a sharper edge in Crohn's

Every low FODMAP article mentions gut bacteria in vague terms. In Crohn's there is a specific, named reason to take it more seriously than a generic caution.

FODMAPs are substrates for colonic bacteria, so removing them changes what grows. In a randomised crossover feeding study, 21 days of a low FODMAP diet raised faecal pH and reduced total bacterial abundance compared with a typical Australian diet, along with shifts in butyrate-producing Clostridium cluster XIVa and mucus-associated Akkermansia muciniphila (Halmos 2015). In IBS, four weeks of the diet reduced Bifidobacterium abundance compared with a sham diet (Staudacher 2017).

The IBD trial found the same pattern with an additional name attached. After four weeks, people on the low FODMAP diet had significantly lower abundance of Bifidobacterium adolescentis, Bifidobacterium longum and Faecalibacterium prausnitzii than those on the control diet, which the authors described as microbes believed to regulate the immune response. Overall diversity and markers of inflammation did not differ (Cox 2020).

Faecalibacterium prausnitzii is not a random bacterium in a Crohn's context. In the study that first characterised its anti-inflammatory properties, researchers found that a reduction in F. prausnitzii on resected ileal Crohn's mucosa was associated with a higher risk of postoperative recurrence, and that a lower proportion was associated with endoscopic recurrence at six months. Its supernatant blocked NF-kappaB activation in cell models and reduced the severity of chemically induced colitis in mice (Sokol 2008).

A 2025 review of low FODMAP in IBD reaches the same conclusion: the diet is best considered a short-term option for people in remission with persistent IBS-like symptoms, with careful management to limit risks to nutritional status and gut microbiota (Skoracka 2025).

The diets that do target Crohn's inflammation are not low FODMAP

If you came here hoping a diet could do something about the disease itself, the answer is not "no". It is "yes, but not this one, and the ones that can look nothing like it".

Exclusive enteral nutrition (EEN) means taking all nutrition as a formula for a set period, typically six to eight weeks. It is the dietary therapy with the strongest evidence for inducing remission in Crohn's. The AGA states it is effective for induction of clinical remission and endoscopic response, with stronger evidence in children than adults, and that it may be considered as a steroid-sparing bridge and before elective surgery in malnourished patients (Hashash 2024). The 2025 ECCO consensus says it is effective for induction of clinical and endoscopic remission in children and adults with mild-to-moderate Crohn's (Svolos 2025). Notice what EEN is: a single formula, containing whatever FODMAPs the formula contains, working by a mechanism that has nothing to do with FODMAP restriction.

The Crohn's disease exclusion diet (CDED) is a whole-food diet combined with partial enteral nutrition, designed to reduce exposure to components thought to affect the microbiome and gut barrier. In a 12-week randomised trial in 74 children with mild to moderate Crohn's, CDED plus partial enteral nutrition was tolerated by 97.5% versus 73.6% for EEN, and at week 12, 75.6% were in corticosteroid-free remission versus 45.1% (Levine 2019). An open-label pilot trial in 40 biologic-naive adults found clinical remission at week 6 in 68% on CDED plus partial enteral nutrition and 57% on CDED alone, with 14 of 40 in endoscopic remission at week 24 (Yanai 2022). That adult trial was a pilot and was not powered for a definitive answer, which the authors say explicitly.

CDED is worth looking at closely if you are tempted to assume all restrictive Crohn's diets are basically the same. It permits chicken, eggs, potatoes, rice and specific fruits and vegetables, and it mandates daily intake of foods such as apple and banana that a low FODMAP elimination phase restricts. The two diets disagree about specific foods because they are aiming at different targets.

CD-TREAT is a food-based diet built to replicate EEN's composition. In a study spanning healthy adults, a rat model and five children with active Crohn's, it reproduced EEN's effects on the faecal microbiome and metabolome, reduced ileitis severity in rats, and in the five children produced a clinical response in four and remission in three, with a large mean fall in calprotectin (Svolos 2019). Five children is five children. It is promising early work, not an established therapy.

Nutrition risk: the part Crohn's makes worse

Restriction is not neutral, and it is less neutral in Crohn's than in IBS. That is the argument the guidelines make most forcefully, and it is the one most likely to apply to you personally.

Reported malnutrition prevalence in IBD ranges widely, from roughly 20% to 85% depending on the population and the definition, driven by reduced intake, malabsorption, chronic blood and protein loss and bacterial overgrowth (Balestrieri 2020). A review of low FODMAP use in IBD put the point bluntly: the risk of compromising nutritional status with a restrictive diet must be seriously considered, especially as undernutrition is already common in this population, and restrictive diets should be supervised by a dietitian (Gibson 2017).

The micronutrient data from IBS are reassuring but not a free pass. In a post hoc analysis of 78 adults with IBS-D, four weeks of a low FODMAP diet reduced intake of several micronutrients compared with a modified NICE diet, but after adjusting for energy intake only riboflavin remained significantly lower, and mean intakes of most micronutrients stayed within recommended allowances. Fewer people met reference intakes for thiamin and iron on the low FODMAP arm (Eswaran 2020). Both diets also reduced daily calories. In someone with Crohn's who is already underweight or already iron deficient, eating fewer calories is not a neutral side effect.

Then there is the behavioural risk. In a clinic study of 161 people with IBD, 92% avoided at least one food while symptomatic and 74% continued avoiding foods even without symptoms. Seventeen percent screened positive for avoidant restrictive food intake disorder, and those people were far more likely to be at risk of malnutrition (60.7% versus 15.8%) (Yelencich 2022). If a restricted diet is starting to feel like a set of rules you cannot break, our guide on whether the low FODMAP diet can cause an eating disorder covers the warning signs and what to do about them.

Both AGA and ESPEN make dietitian access a structural recommendation rather than a nice-to-have. AGA advises that all outpatients and inpatients with complicated IBD are co-managed with a registered dietitian and suggests all newly diagnosed patients have access to one (Hashash 2024). ESPEN's 2023 update runs to 71 recommendations on nutrition in IBD (Bischoff 2023). The British Dietetic Association's IBS guidelines place low FODMAP as second-line advice to be delivered by a dietitian, after first-line healthy eating advice that any healthcare professional can give (McKenzie 2016). The ACG's IBS guideline recommends a limited trial of the diet, with the word "limited" carrying real weight (Lacy 2021).

A worked example: eight weeks, one clear answer

Here is what a properly run trial looks like in Crohn's, as opposed to the version where someone downloads a food list and starts cutting.

The situation. Dan is 34, has ileal Crohn's, had a 20 cm ileocaecal resection four years ago, and has been on maintenance treatment with normal bloods since. For the past six months he has had daily bloating that builds through the afternoon, wind, and two or three loose stools most mornings. No blood, no weight loss, no night-time waking. He assumes it is food and has already cut bread and onion on his own, with partial and inconsistent results.

Weeks 1 to 2: establish the baseline and test, do not cut. Dan logs normally, eating as he usually does. He records stool frequency and Bristol form, bloating and pain on a 0 to 3 scale, urgency, and what he ate with rough timings. He notes his morning pattern specifically, because it is the most consistent thing he has. He asks his IBD nurse for a calprotectin test and mentions the resection, the timing, and the fact that mornings are worst.

Week 3: the results reframe the question. Calprotectin comes back in the normal range, so active inflammation is unlikely to be the driver. Because of the resection and the post-meal, morning-weighted watery stools, his team discusses bile acid diarrhoea and arranges assessment. They also note that his history of a resection raises the odds of bacterial overgrowth. None of that was visible from the food log alone. It came from combining the log with his surgical history.

Weeks 4 to 7: the dietary trial, if it is still warranted. Suppose the bile acid question is settled and there is a residual pattern of bloating that clearly worsens after certain meals. Now a dietitian-led low FODMAP restriction phase makes sense, for four weeks, with a defined endpoint agreed at the start: at least a two-point drop in his average daily bloating score and one fewer loose stool a day. Dan keeps logging identically so the before and after are comparable.

Week 8: decide honestly. Either the endpoint was met, in which case reintroduction begins, one FODMAP group at a time, so he learns which ones actually matter to him rather than avoiding all of them forever. Or it was not met, in which case the diet is stopped and the answer is that FODMAPs were not the problem. The second outcome is a result, not a failure. Continuing for another few months "to be sure" is how people end up with a diet of eight foods and no answer.

The logging is not busywork. It is the only way to get a before and after you can trust, and it is what makes the difference between "I think I feel a bit better" and a decision. Clairop is built for this shape of trial: it compares symptoms after meals with and without a given food across delay windows, and the method page explains why it waits until it has seen at least five meals with and without a food before it shows you anything. If you would rather do it on paper, our guide on how to keep a food diary covers the mechanics, and how to find out what triggers your symptoms explains why a single challenge beats a hunch.

When a low FODMAP trial is probably the wrong move

There are situations where the answer to "should I try it" is reasonably clearly no, or at least not yet.

• Your Crohn's is currently active. The evidence base is entirely in quiescent disease, and the priority during active inflammation is treatment and nutrition.
• You are underweight, losing weight, or have known deficiencies. Adding a restriction that reduces calorie intake is going in the wrong direction. This needs a dietitian regardless.
• You have obstructive symptoms. Those need assessing, not a food list.
• You have not had inflammation ruled out. Symptom relief on a diet is not a test result.
• You have a history of an eating disorder or already feel anxious and controlled around food. Screening and support come first; the risk is well documented in IBD (Yelencich 2022).
• You have already tried it properly and it did not work. Repeating a failed intervention more strictly is a very common and very unrewarding pattern. In one r/CrohnsDisease thread about the diet not working, the thing people found most useful was being able to say they had tried it, so they could stop being told to (r/CrohnsDisease thread).

That last point deserves saying properly. In the community threads, roughly as many people report no benefit as report a clear one, and several describe getting worse on it. Those experiences are not evidence about the diet's average effect, but they are a fair warning that this is not a treatment with a high response rate. Around half the people on the diet in the main trial reported adequate relief, against 16% on a control diet (Cox 2020). That is a meaningful effect and it also means a lot of people get nothing.

Myths worth dropping

Myth: "Low FODMAP reduces inflammation." It does not, in any trial that has looked. Five randomised trials pooled in 2025 found no effect on Crohn's disease activity or faecal calprotectin (Ville 2025), and the largest single trial found no difference in inflammatory markers (Cox 2020).

Myth: "Feeling better means my Crohn's is under control." Symptoms and inflammation come apart in both directions. That is precisely why guidelines lean on biomarkers and endoscopy rather than how someone feels (Mosli 2015).

Myth: "Low FODMAP is basically a bland, low fibre diet." It is not. It permits nuts, seeds, oats and raw vegetables, and excludes soft low fibre foods such as milk and honey. The literature treats reduced fibre for strictures and low FODMAP for functional symptoms as separate interventions (Fitzpatrick 2022).

Myth: "All FODMAPs are equally to blame." In the only blinded rechallenge trial in IBD, fructans produced significantly worse symptoms while galacto-oligosaccharides and sorbitol did not (Cox 2017). Reintroduction exists to find your own version of that.

Myth: "It is a lifelong diet." It was never designed to be. Dietetic guidelines position restriction as a short second-line phase delivered by a dietitian, followed by reintroduction (McKenzie 2016), and the IBD trials ran four to six weeks.

Myth: "If it is not working, I am not doing it strictly enough." Sometimes true, often not. Persistent symptoms on a strict low FODMAP diet are a signal to look for another cause, such as bacterial overgrowth, bile acid diarrhoea or ongoing inflammation, rather than to cut further (Shah 2019, Skouras 2019).

Myth: "Diet is why I got Crohn's, so diet can undo it." No diet has been shown to cure Crohn's, and the AGA states that no diet has consistently been found to decrease flare rates in adults with IBD (Hashash 2024). Enteral nutrition can induce remission, which is a different and much more specific claim.

What to ask your IBD team

Bring the sequence rather than the conclusion. Questions that tend to get useful answers:

• Is my Crohn's currently quiet, and what test are we using to decide that?
• Given my disease location and any surgery I have had, is bile acid diarrhoea or bacterial overgrowth worth testing for?
• Do I have any narrowing that should shape what I eat, and if so is that a texture issue rather than a FODMAP one?
• If we try a low FODMAP diet, can I be referred to a dietitian, how long is the restriction phase, and what will count as it having worked?
• What is the reintroduction plan, and who supports me through it?
• Am I at risk of any deficiencies that we should check before I narrow my diet?

Keeping notes helps here. An average stool count, a rough symptom score over a few weeks and the timing pattern are far more useful in a short appointment than "my stomach is bad". Our guides on preparing for a GI appointment and questions to ask your doctor about Crohn's go into more detail, and there are more in the Crohn's disease section.

When to contact your IBD team

Diet changes should never be a way of riding out symptoms that could mean active disease or a complication. Contact your IBD team promptly rather than adjusting food if you notice any of the following.

Contact your IBD team promptly if you have:

• Blood in your stool, new or increasing
• Stool frequency rising above your usual baseline for more than a few days
• Symptoms that wake you at night
• Unintended weight loss, or eating much less because of symptoms
• New or worsening abdominal pain, particularly after meals
• Feeling unusually tired or breathless, which can be a sign of anaemia
• A new lump, swelling or discharge near the anus
• Symptoms that started after a course of antibiotics, a stomach bug, or regular use of anti-inflammatory painkillers

Seek urgent, same-day medical help if you have:

• Vomiting, severe cramping pain in waves, a swollen abdomen, or not passing wind or stool, which can suggest an obstruction
• A fever, a racing heart, or feeling faint
• Severe or constant abdominal pain, or an abdomen that is tender to touch
• Signs of dehydration such as very little urine, dizziness on standing, or being unable to keep fluids down

The point of settling these questions first is not caution for its own sake. It is that a low FODMAP diet is a reasonable, evidence-backed answer to a narrow question, and a poor answer to almost everything else that can go wrong in Crohn's. Used for the right thing, with an end date and a reintroduction plan, it is one of the more useful tools available for symptoms that treatment cannot reach. Used as a substitute for finding out what is actually happening, it costs you food, nutrition and time, and gives you nothing back.